JAC Advance Access originally published online on October 21, 2004
Journal of Antimicrobial Chemotherapy 2004 54(6):1159; doi:10.1093/jac/dkh461
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JAC vol.54 no.6 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved
Correspondence |
Treatment of Gram-positive bone and joint infection: authors' response
Bristol Centre for Antimicrobial Research and Evaluation, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK
Keywords: osteomyelitis , bone infections , joint infections , antibiotics , Gram-positive
| The first 10% of the full text of this article appears below. |
Sir,
We have noted with interest the points made by Frippiat et al.1 and make the following comments.
We have not stated that the newer quinolones should not be considered for treatment of Gram-positive bone and
* Corresponding author. Tel: +44-117-9595651; Fax: +44-117-9593154; Email: Elizabeth.Darley@north-bristol.swest.nhs.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. M. Queenan and K. Bush Carbapenemases: the Versatile {beta}-Lactamases Clin. Microbiol. Rev., July 1, 2007; 20(3): 440 - 458. [Abstract] [Full Text] [PDF] |
||||
